drugset / Trial / NCT01036854
Pharmacokinetic Study of Ondansetron Administered as IR (Zofran) and MR (EUR1025)
RandomizedParallel-groupSingle-blindTreatment
Summary
The objective of the study is to assess blood levels of ondansetron (EUR1025 24 mg) dose and Zofran 8 mg dose after single and multiple doses are given when taken with a meal and taken on an empty stomach.
Timeline
- Start
- 2009-02
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ondansetron | Other / unclassified | 8 mg | Oral |
| Subject | Ondansetron | Other / unclassified | 16 mg | Oral |
| Subject | Ondansetron | Other / unclassified | 24 mg | Oral |
Indications
No indication recorded.